finance

Novo Nordisk Shares Surge on New Obesity Drug Results




Novo Nordisk shares rose sharply after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients lose 22% of their body weight in a clinical trial.



READ SOURCE

Read More   Omtale Af Europæiske Selskaber Få øje på

This website uses cookies. By continuing to use this site, you accept our use of cookies.